tiprankstipranks
Opyl Limited Unveils AI-Powered ‘Trial Gen’
Company Announcements

Opyl Limited Unveils AI-Powered ‘Trial Gen’

Opyl Ltd. (AU:OPL) has released an update.

Don't Miss our Black Friday Offers:

Opyl Limited has introduced ‘Trial Gen,’ a new module within its TrialKey platform that utilizes artificial intelligence to create tailored clinical trial protocols, promising to revolutionize the efficiency and success of clinical research. Boasting features that optimize trial characteristics and automate the design process, Trial Gen aims to save time and reduce costs for a broad spectrum of clients in the clinical research industry. The tool is versatile enough to support trials from inception or to offer guidance for ongoing research, ensuring broad applicability and scalability.

For further insights into AU:OPL stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App